CE Course 1 - References

References

1. Zoeller J. The top 200 drugs. Am Druggist 1999;Feb:41 -48.

2. Spolarich AE. Understanding pharmacology: the pharmacologic history. Access 1995; 9(3): 33-35.

3. Wynn RL. General principles of drug action. In: Holroyd SV, Wynn RL and Requa-Clark B. Clinical pharmacology in dental practice. 4th ed. St. Louis: CV Mosby Co.1988; pp.9-30.

4. Spolarich AE. Understanding pharmacology: basic principles. Access 1995; 9(6): 25-28.

5. Spolarich AE. Understanding pharmacology: adverse drug effects. Access 1995; 9(10): 28-30.

6. Rang HP, Dale MM, Ritter JM and Gardner R Pharmacology. United Kingdom, Churchill Livingstone, Inc.1995; pp.797-816.

7. Spolarich AE. Understanding pharmacology: medication management. Access 1996; 10(2): 28-30.

8. Spolarich AE. The top 20 most commonly prescribed medications: implications for dental professionals. Compend Cont Educ Oral Hygiene 1999; 6:3-11.

9. Mandel ID. The role of saliva in maintaining oral homeostasis. JADA 1989; 119:298-304

10.Tabak LA et al. Role of salivary mucins in the protection of the oral cavity. J Oral Pathol 1982,11:1 -17.11.Nishioka H, Nishi K and Kyokane K. Human saliva inactivates the mutagenicity of carcinogens. Mutat Res 1981; 85:323-333.

11.Nishioka H, Nishi K and Kyokane K. Human saliva inactivates the mutagenicity of carcinogens. Mutat Res 1981; 85:323-333.

12.Fox PC, van der Ven PF, Sonies BC, Weittenbach JM and Baum BJ. Xerostomia: evaluation of a symptom with increasing significance. JADA 1985,110:519-525.

21.Newbrun E, Hoover Cl and Ryder Ml. Bactericidal action of bicarbonate ion on selected periodontal pathogenic microorganisms. J Periodontol 1984; 55:658-667.

22.Wolinsky LE and Lott T. Effects of the organic salts sodium chloride, sodium bicarbonate and magnesium sulfate upon the growth and motility of Treponema vincentii. J Penodontol 1986; 57: 172-175.

23.Epstein JB and Scully C. The role of saliva in oral health and the causes and effects of xerostomia. J Can Dent Assoc 1992; 58:217-221.

24.Yagiela J. Agents affecting salivation. In: Ciancio SG, ed. ADA Guide to Dental Therapeutics. 1st ed. Chicago: ADA Publishing Co., Inc., 1998:186-198.

25.Levine MJ. Development of artificial salivas. Crit Rev Oral Biol Med 1993; 4:279-286.

26.Fox PC, Atkinson JC, Macynski AA, et al. Pilocarpine treatment of salivary gland hypofunction and dry mouth (xerostomia). Arch Intem Med1991; 151:1149-1152.

27.Johnson JT, Ferretti GA, Nethery WJ, et al. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer. N Engl J Med 1993; 329:390-395.

28.Rhodus NL and Schuh MJ. Effects of pilocarpine on salivary flow in patients with Sjogren's syndrome. Oral Surg Oral Med Oral Pathol 1991; 72:545-549.

29.Wynn R L, Meille r TF and C rossley H L. Drug Information Handbook for dentistry 4th ed Hudson, Ohio:Lexi-Comp Inc. 1998.

30.Wynn RL. Oral pilocarpine (Salagen) - a recently approved salivary stimulant. Gen Dent 1996; 44:26, 29-31.

13.Karmiol M and Walsh RF. Dental caries after radiotherapy of the oral regions. JADA 1975; 91: 838-845.

14.Wright WE. Management of oral sequelae. J Dent Res 1987; 66(Spec Iss): 699-702.

15.Mariotti AJ. Mouth rinses and dentifrices. In: Ciancio SG, ed. ADA Guide to Dental Therapeutics. 1st ed. Chicago: ADA Publishing Co., Inc., 1998:199-213.

16.McGuire S. A review of the impact of fluoride on adult caries. J Clin Dent 1993; 4: 11 -23.

17.Yamamoto J, Fannon ME and McKenzie M. Dental hygiene care: caries prevention and control. In: Darby ML and Walsh MM. Dental hygiene theory and practice. Philadelphia: WB Saunders Co., 1995:557-589.

18.Katz S. The use of fluoride and chlorhexidine for the prevention of radiation caries. JADA 1982; 104:164-170.

19.Lilly JP and Fotos PG. Sjogren's syndrome: diagnosis and management of oral complications. Gen Dent 1996; 44:404408.

20.Scully C. Sjogren's syndrome: clinical and laboratory features, immuno-pathogenesis and management. Oral Surg Oral Med OralPathol 1986; 62:510-523.

31.Edwardsson S, Birkhed D and Mejare B. Acid production from Lycasin@, maltitol, sorbitol and xylitol by oral streptococci and lactobacilli. Acta Odontol Scand 1977; 35:257-263.

32.Jensen M. Effects of chewing sorbitol gum and paraffin on human interproximal plaque pH. Caries Res 1986; 20:503-509.

33.Jensen ME. Responses of interproximal plaque pH to snack foods and effect of chewing sorbitol-containing gum. JADA 1 986; 113:262-266.

34.Park KK, Schemehorn BR, Bolton JW and Stookey GK. The impact of chewing sugarless gum on the acidogenicity of fastfood meals. Am J Dent 1990; 3:231-235.

35.Ciancio SG (ed). Dental caries and chewing gum; plaque pH, dental caries and chewing gum; increase in salivary flow and remineralization with sugarless gum. Biological Therapies in Dentistry 1989; 5(2): 5-8.

36.Papas A, Stack KM and Spodak D. Sonic tooth brushing increases saliva flow rate in Sjogren's syndrome patients. J Dent Res 1998 in press.

37.Twetman S and Lindquist L. Effect of salivary Iysozyme on glucose incorporation and acid production of Streptococcus mutans. Caries Res 1985; 19:414-421.

38.Arnold RR, Brewer M and Gauthier JJ. Bactericidal activity of human lactoferrin: sensitivity of a variety of organisms. Infect Immun 1980; 28:893-898.

39.Lassiter MO et al. Characterization of lactoferrin interaction with Streptococcus mutans. J Dent Res 1987; 66:480-485.

40.Tenovuo J et al. Inhibition of dental plaque acid production by the salivary lactoperoxidase system. Infect Immun 1981; 34:208-14.

41.Fine DH. Chemical agents to prevent and regulate plaque development. Periodontology 2000 1995; 8:87-107.

42.Davies A. The mode of action of chlorhexidine. J Periodont Res (Suppl) 1973; 12:68-75.

43.Schiott R and Loe H. The sensitivity of oral streptococci to chlorhexidine. J Periodont Res 1972; 7:192-194.

44.Council on Dental Therapeutics. Council on Dental Therapeutics accepts Listerine. JADA 1988; 117:515-516.

45. Lamster IB et al. The effect of Listerine antiseptic on reduction of existing plaque and gingivitis. Clin Prev Dent 1983; 5:12-16.

46.DePaola LG et al. Effect of an antiseptic mouth rinse on salivary microbiota. Am J Dent 1996; 9:93-95.

47.Kubert D et al. Antiseptic mouth rinse-induced microbial cell surface alterations. Am J Dent 1993; 6:277-279.

48.Kurik T, Lieb R, Furgang D et al. Effect of Listerine antiseptic on in-vitro coaggregation of oral bacteria. J Dent Res 1992; 71: 215.

49.Fine DH et al. Effects of sublethal exposure to an antiseptic mouth rinse on representative plaque bacteria. J Clin Periodontol 1996; 23:444-451.

50.Minah GE et al. Effects of 6 months use of an antiseptic mouth rinse on supragingival dental plaque microflora. J Clin Periodontol 1989; 16:347-352.

51.Pollock JJ et al. Fungistatic and fungicidal activity of the human parotid salivary histidine-rich polypeptides on Candida albicans. Infect Immun 1984; 44:702-707.

52.Glass BJ. Drug-induced xerostomia as a cause of glossodynia. Ear Nose Throat J 1989; 68:776-781.

53.Somerman M. Antifungal and antiviral agents. In: Ciancio SG, ed. ADA Guide to Dental Therapeutics. 1st ed Chicago: ADA Publishing Co., 1 nc.1998: 164- 174.

54.Epstein JB, Vickars L, Spinelli J and Reece D. Efficacy of chlorhexidine and nystatin rinses in prevention of oral complications in leukemia and bone marrow transplantation. Oral Surg Oral Med Oral Pathol 1992; 73:682-689.

55.Langslet A, Olsen I, Lie SO and Lokken P Chlorhexidine treatment of oral candidiasis in seriously diseased children. Acta Paediatr Scand 1974; 63:809-811.

56.Ferretti GA, Largent BM, Ash RC, Kaplan A, Brown AT and Lillich TT. Chlorhexidine for prophylaxis against oral infections and associated complications in patients receiving bone marrow transplants. JADA 1987; 114:461-467.

57.Ferretti GA, Ash RC, Brown AT, Parr MD, Romond EH and Lillich TT. Control of oral mucositis and candidiasis in marrow transplantation: a prospective, double-blind trial of chlorhexidine digluconate oral rinse. Bone Marrow Transplant 1988; 3:483-493.

58.Sharon A, Berdicevsky I, Ben-Aryeh H and Gutman D. The effect of chlorhexidine mouth rinses on oral Candida in a group of leukemic patients. Oral Surg Oral Med Oral Pathol 1977; 44:201 -205.

59.DePaola LG, Minah GE, Leupold RJ, Faraone KL and Elias SA. The effect of antiseptic mouth rinses on oral microbial flora and denture stomatitis. Clin Prev Dent 1986; 8:3-8.

60.DePaola L and Minah G. The effect of Listerine antiseptic mouth rinses and Efferdent denture soaks on denture stomatitis and denture microbial flora. J Dent Res 1987,66(Spec Issue), IADR abstract no.1692.

61.Archibald DW et al. Salivary antibodies as a means of detecting human T-cell Iymphotrophic virus type III/lymphadenopathy-associated virus infection. J Clin Microbiol 1986; 24:873875.

62.Heineman HS and Greenberg MS. Cell protective effect of human saliva specific for herpes simplex virus. Arch Oral Biol 1980; 25:257-261.

63.Fox P et al. Saliva inhibits HIV-1 infectivity. JADA 1988; 116:635-637.

64.Meiller TF, Kutcher MJ, Overholser CD, Niehaus C, DePaola LG and Siegel MA. Effect of an antimicrobial mouth rinse on recurrent apthous ulcerations. Oral Surg Oral Med Oral Pathol 1991; 72:425-429.

65.Greer RO Jr, Lindenmuth JE, Juarez T et al. A double-blind study of topically applied 5% amlexanox in the treatment of aphthous ulcers. J Oral Maxillofac Surg 1993; 51: 243-248.

66.Hunter L and Addy M. Chlorhexidine gluconate mouthwash in the management of minor aphthous ulceration. Br Dent J 1987; 162:106-110.

67.Matthews RW, Scully CM, Levers BGH. Clinical evaluation of benzydamine, chlorhexidine, and placebo mouthwashes in the management of recurrent aphthous stomatitis. Oral Surg OralMedOralPathol1987; 63:189-191.

68.Bowen DM. Personal mechanical oral hygiene care and chemotherapeutic plaque control. In: Darby ML and Walsh MM. Dental Hygiene Theory and Practice. Philadelphia: WB Saunders Co., 1 995:435-460.

69.Grossman E, Dembling W and Proskin H. A comparative clinical investigation of the safety and efficacy of an oscillating/rotating electric toothbrush and a sonic toothbrush. d Clin Dent 1995; 6:108-114.

70.1saacs RL, Beiswanger BB, Rosenfield ST, et al. A crossover clinical investigation of the safety and efficacy of a new oscillating/rotating electric toothbrush and a high frequency electric toothbrush. Am J Dent 1998; 11: 7-12.

71.Rapley JW and Killoy WJ. Subgingival and interproximal plaque removal using a counter rotational electric toothbrush and a manual toothbrush. Quintessence Int 1994; 25:39-42.

72.Stoltze K and Bay L. Comparison of a manual and a new electric toothbrush for controlling plaque and gingivitis. J Clin Periodontol 1994; 21:86-90.

73.Van der WeiJden FA, Timmerman MF, Snoek IM, et al. Tooth brushing duration and plaque removing efficacy of electric toothbrushes. Am J Dent 1996; 9:S31 -S36.

74.Johnson BD and Mclnnes C. Clinical evaluation of the efficacy and safety of a new sonic toothbrush. J Periodontol 1994; 65; 692-697.

75.Tritten CB and Armitage GC. Comparison of a sonic and a manual toothbrush for efficacy in supragingival plaque removal and reduction of gingivitis. J Clin Periodontol 1996; 23:641648.

76.Robinson PJ, Maddalozzo D and Breslin S. A six-month clinical comparison of the efficacy of the Sonicare and the Braun Oral-B electric toothbrushes on improving periodontal health in adult periodontitis patients. J Clin Dent 1997; 8:4-9.

77.Yankell SL, Emling RC and Shi X. Interproximal access efficacy of Sonicare Plus and Braun Oral-B Ultra compared to a manual toothbrush. J Clin Dent 1997; 8:26-29.

78.Ciancio SG, Mather ML, Reynolds HS and Zambon JJ. The effect of oral irrigation with Listerine on plaque, gingivitis, and the subgingival microflora. J Dent Res 1987; 66(Spec Issue), lADR abstract no.1026.

79.Dawes C. A mathematical model of salivary clearance of sugar from the oral cavity. Caries Res 1983; 17:321.

80.Mecklenburg RE, Christen AG, et al. How to help your patients stop using tobacco. US Dept of Health and Human Services, Public Health Service, National Institutes of Health NIH Publ 91-3191, September, 1991.

81.Geboy MJ and Fried JL. A model curriculum for tobacco use cessation and prevention intervention. Health Values 1994; 18:96-101.

82.Fried JL. Tobacco use intervention: the role of the dental hygienist. Dental Hygiene News 1992; 5:2-3.

83.Fried JL and Rubinstein L. Dental hygienists'anti-tobacco role: educational perspectives. J Dent Educ 1989; 53:712-717.